De godkendte indikationer er lokalt avanceret prostatacancer som umiddelbar behandling enten alene eller i kombination med anden behandling eller som adjuverende behandling til radikal prostatektomi eller strålebehandling.
Its authorised indications include the treatment of patients with locally advanced prostate cancer, as an immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy.